Global expansion and tax planning
Challenge: Navigating new financial reporting and tax requirements
As life sciences companies expand into new countries, they face the challenge of adapting to new financial reporting and tax requirements. Like the regulatory issues described previously, these requirements can be major hurdles to clear, and adhering to them can consume significant time and resources.
Opportunity: Accessing tax incentives and innovation support
As companies expand into new international markets, international tax planning and transfer pricing can become critical components in management’s global strategy. By proactively reviewing their operations, companies open up the opportunity to optimize their tax positions and strategically structure transactions.
Management can lay the groundwork for effective international tax planning by analyzing the tax implications of entering a new market, including understanding local tax incentives. Furthermore, adopting the right holding or principal structure can help drive efficiency in cash repatriation. Similarly, management can build the foundations of an effective transfer pricing strategy by analyzing intercompany transactions and market conditions across different geographic locations. Through careful analysis, companies can unlock value by aligning both tax planning and transfer pricing with overall business strategies while simultaneously mitigating tax risks.
An effective team should focus on:
U.S. GAAP analysis for international operations. Analyze the implications of establishing new entities and contracts abroad; align financial statements and practices.
Transfer pricing compliance and documentation. Assess compliance and prepare transfer pricing documentation to facilitate penalty protection. Align transfer prices with market rates and transactions.
International tax planning. Review current business structures, including opportunities for tax planning related to supply chain optimization and intellectual property management.